U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español

Reuters Health Information Logo

Rising uric acid levels tied to migraine drug

Printer-friendly version Printer-friendly version

Reuters Health

Wednesday, August 27, 2008

NEW YORK (Reuters Health) - In migraine patients, treatment with the drug topiramate (sold as Topamax) may result in increasing blood levels of uric acid, a study shows.

Some research has linked high uric acid levels in the body to a higher risk of cardiovascular trouble. Excess uric acid in the body can create oxidative stress, a state that damages body cells and contributes to diseases, including the buildup of artery-clogging plaques.

Decreases in body weight and the development of kidney stones have been reported with topiramate use, the investigators explain, but changes in uric acid and lipid levels have not been studied.

Dr. Abdulkadir Kocer from Duzce University, Duzce, Turkey and colleagues measured blood uric acid, cholesterol, and triglyceride levels in 53 patients with migraine who were receiving topiramate, as well as in 44 matched control subjects not treated with this drug.

Average uric acid levels were significantly higher in the migraine patients receiving topiramate than in healthy controls, the investigators report. Average serum triglyceride and total cholesterol levels were also higher in the migraine group, but the differences were not statistically significant.

Among patients for whom pretreatment uric acid levels were known, average uric acid levels were significantly higher after initiation of treatment than in the pretreatment measurements.

"We think that there is a need for careful monitoring of the serum uric acid and lipid profile in patients receiving topiramate," the researchers conclude.

Considering the potential link between abnormally high uric acid levels and cardiovascular complications, "more emphasis should be put on the topiramate-related complications" such as high uric acid levels, they add.

SOURCE: Headache, July/August 2008.


Reuters Health

Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: